The Effect of a Non-Specifically Acting Transfer Factor Component on Cellular Immunity in Juvenile Rheumatoid Arthritis
- 1 January 1976
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 5 (3) , 151-157
- https://doi.org/10.3109/03009747609165454
Abstract
A chromatographically purified component of human dialysable transfer factor with a non-specific stimulatory effect on the expression of immune response was used in a therapeutic trial in 8 cases of juvenile rheumatoid arthritis. Enhancement of the delayed type of immune response, measured by skin testing, was seen in all cases, but in vitro reactions to test antigens were unaltered. Clinical improvement was seen in all patients with acute history and in 2 of the 5 chronic cases, but it is not certain whether this was caused by the improved immune reactivity, or whether this reflected the known variable natural history of the disease.This publication has 5 references indexed in Scilit:
- URACIL IN TRANSFER FACTORThe Lancet, 1975
- Therapeutic Use of Transfer FactorEuropean Journal of Clinical Investigation, 1975
- The Principle of Immunopotentiation in Treatment of Rheumatoid Arthritis: Effect of Transfer FactorScandinavian Journal of Immunology, 1974
- Does Transfer Factor Act Specifically or as an Immunologic Adjuvant?New England Journal of Medicine, 1973
- Transfer FactorPublished by Elsevier ,1969